Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,043 | 985 | 96.7% |
| Travel and Lodging | $418.67 | 1 | 3.1% |
| Education | $30.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,905 | 261 | $0 (2024) |
| ABBVIE INC. | $1,283 | 104 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,210 | 99 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $974.36 | 49 | $0 (2024) |
| PFIZER INC. | $970.17 | 107 | $0 (2024) |
| Abbott Laboratories | $890.95 | 30 | $0 (2024) |
| Boston Scientific Corporation | $731.59 | 10 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $536.40 | 35 | $0 (2024) |
| Lilly USA, LLC | $430.87 | 47 | $0 (2024) |
| Amgen Inc. | $380.01 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,745 | 117 | PFIZER INC. ($286.46) |
| 2023 | $1,816 | 145 | ABBVIE INC. ($386.85) |
| 2022 | $2,241 | 157 | ABBVIE INC. ($372.30) |
| 2021 | $2,453 | 158 | Novo Nordisk Inc ($387.53) |
| 2020 | $941.48 | 75 | Abbott Laboratories ($210.15) |
| 2019 | $1,285 | 108 | Novo Nordisk Inc ($258.05) |
| 2018 | $1,785 | 128 | Boston Scientific Corporation ($670.97) |
| 2017 | $1,225 | 100 | GlaxoSmithKline, LLC. ($228.64) |
All Payment Transactions
988 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.34 | General |
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.41 | General |
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | Biogen, Inc. | QALSODY (Drug), SPINRAZA | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Biological | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diagnostics | ||||||
| 09/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.56 | General |
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,891 | 2,638 | $226,772 | $118,926 |
| 2022 | 17 | 2,266 | 3,090 | $250,408 | $137,114 |
| 2021 | 22 | 3,429 | 4,838 | $353,593 | $205,624 |
| 2020 | 20 | 2,639 | 3,761 | $264,296 | $138,565 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 443 | $64,585 | $40,335 | 62.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 223 | 223 | $58,325 | $27,815 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 285 | 445 | $49,240 | $24,597 | 50.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $8,100 | $7,614 | 94.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 382 | 645 | $16,105 | $5,415 | 33.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 196 | 196 | $4,900 | $3,485 | 71.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 77 | 77 | $2,772 | $2,295 | 82.8% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 39 | 39 | $5,265 | $2,092 | 39.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 77 | 77 | $2,310 | $1,685 | 72.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 201 | 238 | $5,950 | $811.58 | 13.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $1,800 | $771.64 | 42.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 76 | $3,268 | $739.85 | 22.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $864.00 | $715.44 | 82.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $1,606 | $242.00 | 15.1% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 11 | $400.00 | $170.23 | 42.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 61 | $732.00 | $71.20 | 9.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 17 | 22 | $550.00 | $70.62 | 12.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 316 | 515 | $74,675 | $46,747 | 62.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 358 | 522 | $57,420 | $30,785 | 53.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 240 | 240 | $48,000 | $30,478 | 63.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 26 | 26 | $7,800 | $7,222 | 92.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 79 | 80 | $10,800 | $4,838 | 44.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 220 | 220 | $5,500 | $3,892 | 70.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 439 | 709 | $17,725 | $2,097 | 11.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $4,050 | $2,079 | 51.3% |
About Dr. John Monroe, M.D
Dr. John Monroe, M.D is a Family Medicine healthcare provider based in Goodyear, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346312451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Monroe, M.D has received a total of $13,491 in payments from pharmaceutical and medical device companies, with $1,745 received in 2024. These payments were reported across 988 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,043).
As a Medicare-enrolled provider, Monroe has provided services to 10,225 Medicare beneficiaries, totaling 14,327 services with total Medicare billing of $600,228. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Goodyear, AZ
- Active Since 11/14/2006
- Last Updated 12/04/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346312451
Products in Payments
- Ozempic (Drug) $977.72
- JARDIANCE (Drug) $791.05
- TRELEGY ELLIPTA (Drug) $742.35
- UBRELVY (Drug) $682.49
- WATCHMAN (Device) $586.95
- NURTEC ODT (Drug) $434.75
- ELIQUIS (Drug) $385.55
- VRAYLAR (Drug) $341.51
- QULIPTA (Drug) $339.42
- CardioMEMS HF System (Device) $329.58
- Adempas (Drug) $307.47
- XIFAXAN (Drug) $295.91
- INJECTAFER (Drug) $238.60
- Rybelsus (Drug) $237.45
- CHANTIX (Drug) $236.86
- ENTRESTO (Drug) $226.25
- JANUVIA (Drug) $197.19
- Victoza (Drug) $185.29
- SOLIQUA 100/33 (Biological) $177.82
- XARELTO (Drug) $167.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goodyear
Mr. Mark Lonquist, Md, MD
Family Medicine — Payments: $15,985
Dr. Darrin Scherer, D.o, D.O
Family Medicine — Payments: $4,006
Tricia Stytle, D.o, D.O
Family Medicine — Payments: $4,003
Dr. Natalie Lake, Md, MD
Family Medicine — Payments: $3,472
Dr. Nathan Tholl, M.d, M.D
Family Medicine — Payments: $2,157
Dr. David Jensen, D.o, D.O
Family Medicine — Payments: $1,735